Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer

Colorectal cancer (CRC) currently ranks as the third most common cancer in the United States, and its incidence is on the rise, especially among younger individuals. Despite the remarkable success of immune checkpoint inhibitors (ICIs) in various cancers, most CRC patients fail to respond due to int...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Dechen Wangmo, Travis J. Gates, Xianda Zhao, Ruping Sun, Subbaya Subramanian
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2024-01-01
Schriftenreihe:	Vaccines
Schlagworte:	colorectal cancer CEP55 immune regulation T cells immune checkpoint inhibition
Online-Zugang:	https://www.mdpi.com/2076-393X/12/1/63
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!